ARTICLE | Clinical News
Gepirone ER: Phase III data
July 4, 2005 7:00 AM UTC
In the double-blind, placebo-controlled, U.S. Phase III FKGBE008 in 206 patients, gepirone ER improved depressive symptoms, but failed to reach statistical significance at week 8 compared with placebo...